rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Ranbaxy Laboratories

Rediff.com  »  News  »   Ranbaxy Laboratories

  News for Ranbaxy Laboratories

  • Business

Ranbaxy merger: Sun Pharma readies new leadership team

Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has put in place a team of top executives, including Dilip Shanghvi's son Aalok Shanghvi, to lead the businesses of both the......

Sun Pharma gets US trade regulator nod for Ranbaxy deal

The US Federal Trade Commission (FTC) has completed its review of the proposed $4 billion acquisition of Ranbaxy Laboratories by Sun Pharma and granted early termination of the waiting period under......

Ranbaxy Q3 net loss widens to Rs 1,029 cr on forex woes

Ranbaxy Laboratories on Wednesday reported widening of its consolidated net loss to Rs 1,029.72 crore (Rs 10.29 billion) for the third quarter ended December 31, 2014, as higher costs and foreign......

US court rejects Ranbaxy' plea to block launch by rival cos

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court......

Ranbaxy sues US FDA for revoking drug approvals

FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte Ranbaxy Laboratories Ltd has sued the US Food and Drug Administration (FDA) for revoking approvals granted to the firm to......
  Web results for Ranbaxy Laboratories
DLF to stay in BSE's Group A category

The Bombay Stock Exchange (BSE) has said that the real estate giant DLF will remain in Group A category, comprising top 300 companies. The... ...

http://www.millenniumpost.in/NewsContent.aspx?NID=112449
Sun Pharma Says Shanghvi Did Not Buy Shares From Daiichi Sankyo

, 13:22 [IST] Sun Pharma today clarified to the stock exchanges that its promoter Dilip Shanghvi did not buy shares sold by Daiichi Sankyo... ...

http://www.goodreturns.in/news/2015/04/22/sun-pharma-says-shanghvi-did-not-buy-shares-from-daiichi-sankyo-351560.html
Sun Pharma advances on fund buying

Sun Pharmaceutical Industries rose 2.21% to Rs 972.65 at 11:45 IST on BSE after foreign funds purchased bulk shares in secondary equity market on... ...

http://www.capitalmarket.com/CMEdit/story2-0.asp?SNo=767780
Sun Pharma shares bounce back, up by 3 per cent on bourses

Sun Pharmaceutical Industries Ltd slumped as much as 10.9 per cent Mumbai: Stocks of Sun Pharmaceutical made acomeback at the bourses today,... ...

http://www.deccanchronicle.com/150422/business-companies/article/sun-pharma-shares-bounce-back-3-cent-bourses
Daiichi Sankyo's misery ends, block deal gives co the final coup de grĂ¢c

Even after allowing for control premium, the price that Daiichi Sankyo paid for Ranbaxy Laboratories was clearly excessive, and those in the know... ...

http://www.firstpost.com/business/daiichi-sankyos-misery-ends-block-deal-gives-co-the-final-coup-de-grac-2205840.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z